PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Peptide fractions from lima bean protein showed in vitro ACE-inhibitory and renin-inhibitory activities, and antihypertensive activity was confirmed in vivo using a rat model [PMID: 28707727]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 30372004 (2006) — Insight into the structural basis of the dual inhibitory mode of Lima bean (Phaseolus lunatus) serine protease inhibitor. · Proteins
- 2.PMID: 37683050 (2024) — Lima bean (Phaseolus lunatus Linn.) protein isolate as a promising plant protein mixed with xanthan gum for stabilizing oil-in-water emulsions. · Journal of the science of food and agriculture
- 3.PMID: 26151849 (2015) — Transcriptome Sequencing of Lima Bean (Phaseolus lunatus) to Identify Putative Positive Selection in Phaseolus and Legumes. · International journal of molecular sciences
- 4.PMID: 30364341 (2018) — Resistance of Lima Bean (Phaseolus lunatus L.) to the Red Spider Mite Tetranychus neocaledonicus (Acari: Tetranychidae). · Frontiers in plant science
- 5.PMID: 31240396